Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) shares rose 8.3% during trading on Friday . The company traded as high as $5.00 and last traded at $4.85, with a volume of 515,661 shares changing hands. The stock had previously closed at $4.48.

CLMT has been the subject of a number of research reports. Howard Weil lowered their target price on Calumet Specialty Products Partners, L.P from $19.00 to $5.00 and set a “sector underperform” rating for the company in a research report on Monday, April 18th. Royal Bank Of Canada downgraded Calumet Specialty Products Partners, L.P from an “outperform” rating to a “sector perform” rating and lowered their target price for the company from $22.00 to $7.00 in a research report on Monday, April 18th. Drexel Hamilton reiterated a “hold” rating and set a $16.00 target price on shares of Calumet Specialty Products Partners, L.P in a research report on Tuesday, April 12th. Zacks Investment Research downgraded Calumet Specialty Products Partners, L.P from a “hold” rating to a “strong sell” rating in a research report on Friday, May 6th. Finally, DA Davidson upgraded Calumet Specialty Products Partners, L.P from an “underperform” rating to a “neutral” rating and set a $5.00 target price for the company in a research report on Thursday, May 5th. Five research analysts have rated the stock with a sell rating and eleven have issued a hold rating to the company’s stock. Calumet Specialty Products Partners, L.P has an average rating of “Hold” and a consensus price target of $10.71.

The firm has a 50 day moving average of $4.74 and a 200-day moving average of $8.20. The firm’s market capitalization is $371.19 million.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last posted its quarterly earnings data on Thursday, August 4th. The company reported ($1.89) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by $1.55. Analysts predict that Calumet Specialty Products Partners, L.P will post ($1.84) EPS for the current year.

In other Calumet Specialty Products Partners, L.P news, Director James S. Carter acquired 26,700 shares of the business’s stock in a transaction dated Tuesday, May 17th. The stock was acquired at an average cost of $3.72 per share, for a total transaction of $99,324.00. Following the completion of the transaction, the director now directly owns 66,341 shares of the company’s stock, valued at $246,788.52. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Stephen P. Mawer acquired 11,000 shares of the business’s stock in a transaction dated Wednesday, May 18th. The stock was acquired at an average price of $3.68 per share, with a total value of $40,480.00. Following the completion of the transaction, the director now directly owns 5,025 shares of the company’s stock, valued at $18,492. The disclosure for this purchase can be found here.

A hedge fund recently bought a new stake in Calumet Specialty Products Partners, L.P stock. Marshall Wace LLP acquired a new position in shares of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 209,614 shares of the company’s stock, valued at approximately $4,173,000. Marshall Wace LLP owned about 0.28% of Calumet Specialty Products Partners, L.P as of its most recent filing with the SEC.

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products. The Company operates through three segments. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.